海外の治験の状況「前立腺癌」での検索結果
370件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients with Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
- Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer br>C61
- Argentina, Australia, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Mexico, Netherlands, Peru, Poland, Puerto Rico, Romania, Spain, Sweden, Turkey, United Kingdom, United States
- 2011-11-13
Not Recruiting
- A PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY MODULATED RADIOTHERAPY FOR PROSTATE CANCER
- localized prostate cancer
- China
- 2011-07-13
Not Recruiting
- The impact of the Applied Progressive Muscle Relaxation Training to the level of Depression, Anxiety, Stress and Quality of Life among Prostate Cancer Patients
- prostate cancer patients. br>C61 Malignant neoplasm of prostate;C61 Malignant neoplasm of prostate
- Malaysia
- 2011-04-16
Not recruiting
- A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
- Hormone Refractory Prostate Cancer
- Russian Federation
- 2007-03-15
Not recruiting
- Taxotere Prostate Cancer New Indication Registration Trial in China
- Prostatic Neoplasms
- China
- 2007-02-16
Not recruiting
- Safety Evaluation of ExAblate MRgFUS for Prostate Cancer
- Prostate Cancer
- Israel
- 2008-12-17
Not recruiting
- MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
- Prostate Cancer
- Belgium, France, Germany, Israel, Spain, Switzerland
- 2001-12-07
Not recruiting
- One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population
- Prostate Cancer
- China
- 2012-12-05
Not Recruiting
- A Randomized, Double-Blind, Parallel-Group Trial Comparing Bicalutamide (Casodex) 150mg Once Daily With Placebo in Patients With Non-metastatic Prostate Cancer
- Non-Metastatic Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Austria, Belgium, Czech Republic, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Poland, Portugal, South Africa, Spain, United Kingdom
- 2015-11-12
Not Recruiting
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer
- Neoplasms, Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom, United States
- 2015-11-12